Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

Announcement on the Achievement of Performance Assessment Targets for the 2nd Lock-up Period of the 2024 Employee Stock Ownership Plan and the Expiry of the Lock-up Period

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on the Achievement of Performance Assessment Targets for the 2nd Lock-up Period of the 2024 Employee Stock Ownership Plan and the Expiry of the Lock-up Period

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Company analysis